Merriman Curhan Ford Maintains a 'Buy' on Cyclacel Pharmaceuticals (CYCC); Raises PT Range Feb 17, 2010 11:13AM
Notable Analyst Rating Changes 9/18: ETFC, SNDK, TOL, SBUX, PG, AMED Upgraded; SCHW, GENZ, MDC, IMAX, MOT Downgraded Sep 18, 2009 10:37AM
Notable Analyst Rating Changes 2/4: RVBD, UPS, RSYS Upgraded; ADM, DIS, STI, WYNN Downgraded Feb 4, 2009 09:41AM
Notable Analyst Rating Changes 1/6: AAPL, GOOG, YRCW Upgraded; GRMN, ICE, ATHN, ENDP Downgraded Jan 6, 2009 10:10AM
Notable Analyst Rating Changes 7/1: SIRI, AXP, NVDA, CTAS Upgraded; FO, ALTR, RBN Downgraded Jul 1, 2008 09:53AM